BAXTER INTERNATIONAL INC acquired Cheetah Medical, Inc. (Cheetah) for $188 million total cash consideration net of cash acquired, plus up to $40 million of contingent consideration (acquisition-date fair value $18 million), a transaction completed in October 2019, structured as all cash (with contingent consideration).
Cheetah Medical, Inc. (Cheetah) operates in Patient monitoring / hemodynamic monitoring, is based in Newton Center, Massachusetts, USA. Cheetah Medical is a provider of non-invasive fluid management and hemodynamic monitoring technologies used to guide fluid administration decisions in critical and surgical care.
Adds non-invasive hemodynamic monitoring and fluid management technology that complements Baxter's acute care and critical-care portfolio.
Non-invasive hemodynamic monitoring technology complementary to Baxter's acute and critical-care therapies. Integrated into Baxter's acute care / critical care business
On October 25, 2019, we acquired 100 percent of Cheetah Medical, Inc. (Cheetah) for total cash consideration of $188 million, net of cash acquired, with the potential for additional cash consideration, up to $40 million, based on clinical and commercial milestones for which the acquisition date fair value was $18 million.Baxter FY2021 10-K, Acquisitions note
Advisory firms were not disclosed for this transaction.